The mean penetrance of pathogenic RYR2 variants causing CPVT is 83 %, with mortality rates of 30–50 % by age 35 years, and consequently, asymptomatic carriers are rare [20, 22]. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.